Related Experiment Videos
The SH2-containing adapter protein GRB10 interacts with BCR-ABL
1Department of Internal Medicine III, Technical University of Munich, Germany.
Oncogene
|September 25, 1998
Summary
Researchers identified Grb10 as a novel binding partner for Bcr-Abl tyrosine kinase, crucial for Bcr-Abl-induced IL-3 independence in hematopoietic cells. This discovery sheds light on leukemia pathogenesis and potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Bcr-Abl is an oncogenic tyrosine kinase implicated in chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL).
- Bcr-Abl possesses autophosphorylation sites that mediate interactions with SH2-containing signaling molecules, critical for its transforming activity.
- While Grb2 binding to Bcr-Abl (Tyr177) links it to the Ras pathway, its precise biological role remains unclear, as a Tyr177-mutated Bcr-Abl retains transforming capabilities.
Purpose of the Study:
- To identify novel signaling proteins interacting with Bcr-Abl autophosphorylation sites using a yeast two-hybrid system.
- To elucidate the functional significance of the interaction between Bcr-Abl and its binding partners in cellular transformation and leukemia development.
Main Methods:
- Yeast two-hybrid screening using a full-length Bcr-Abl fusion protein to identify SH2-containing binding partners.
- In vitro and in vivo binding assays, including co-immunoprecipitation, to confirm interactions.
- Mutational analysis of Bcr-Abl to map binding sites and assess functional consequences.
- Overexpression of Bcr-Abl and its mutants in hematopoietic cells (Ba/F3) to evaluate IL-3 dependence and focus formation assays in fibroblasts.
Main Results:
- The yeast two-hybrid screen identified known Bcr-Abl interactors (Grb2, PI-3-kinase, Crk) and the novel SH2-containing protein Grb10.
- Grb10 binds to a distinct site on Bcr-Abl (between Bcr aa242-446) in a phosphotyrosine-dependent manner, requiring kinase activity.
- A Bcr-Abl mutant lacking Grb10 interaction partially alleviated IL-3 dependence in Ba/F3 cells and showed reduced focus-forming capacity in fibroblasts.
Conclusions:
- Grb10 is a novel, functionally relevant binding partner of Bcr-Abl tyrosine kinase.
- The interaction between Grb10 and Bcr-Abl plays a role in Bcr-Abl-mediated IL-3 independence, a key event in leukemogenesis.
- Targeting the Bcr-Abl/Grb10 interaction may offer a therapeutic strategy for CML and ALL.